Definitive Healthcare (NASDAQ:DH) Shares Up 8.4% – Here’s What Happened

Definitive Healthcare Corp. (NASDAQ:DH) shot up 8.4% during trading on Friday . The stock traded as high as $4.70 and last traded at $4.67. 124,458 shares changed hands during trading, a decline of 83% from the average session volume of 745,816 shares. The stock had previously closed at $4.31.

Analysts Set New Price Targets

Several research firms have recently weighed in on DH. BTIG Research assumed coverage on shares of Definitive Healthcare in a research note on Tuesday, September 17th. They issued a “buy” rating and a $7.00 target price for the company. Barclays reduced their price objective on shares of Definitive Healthcare from $6.00 to $4.00 and set an “equal weight” rating for the company in a research note on Wednesday, August 7th. Stifel Nicolaus dropped their target price on Definitive Healthcare from $9.50 to $7.50 and set a “buy” rating on the stock in a research report on Wednesday, July 31st. Morgan Stanley reduced their price target on Definitive Healthcare from $9.00 to $5.00 and set an “equal weight” rating for the company in a research report on Tuesday, August 6th. Finally, Robert W. Baird dropped their price objective on Definitive Healthcare from $6.00 to $5.00 and set a “neutral” rating on the stock in a report on Wednesday, August 7th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $5.81.

Definitive Healthcare Trading Down 1.6 %

The company has a debt-to-equity ratio of 0.27, a current ratio of 2.40 and a quick ratio of 2.40. The stock has a market cap of $500.02 million, a P/E ratio of -1.22, a PEG ratio of 6.27 and a beta of 1.33. The firm’s fifty day moving average price is $4.36 and its two-hundred day moving average price is $5.00.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Swiss National Bank raised its position in Definitive Healthcare by 2.9% during the first quarter. Swiss National Bank now owns 103,300 shares of the company’s stock valued at $834,000 after purchasing an additional 2,900 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in Definitive Healthcare by 17.0% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,896 shares of the company’s stock worth $125,000 after buying an additional 3,332 shares during the last quarter. Principal Financial Group Inc. boosted its stake in Definitive Healthcare by 10.8% in the second quarter. Principal Financial Group Inc. now owns 39,856 shares of the company’s stock worth $218,000 after buying an additional 3,874 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank grew its position in Definitive Healthcare by 31.4% during the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,292 shares of the company’s stock valued at $116,000 after acquiring an additional 5,083 shares during the last quarter. Finally, Valeo Financial Advisors LLC raised its stake in shares of Definitive Healthcare by 11.8% during the second quarter. Valeo Financial Advisors LLC now owns 59,080 shares of the company’s stock worth $323,000 after acquiring an additional 6,230 shares in the last quarter. Hedge funds and other institutional investors own 98.67% of the company’s stock.

About Definitive Healthcare

Definitive Healthcare Corp., together with its subsidiaries, provides software as a service (SaaS) healthcare commercial intelligence platform in the United States and internationally. Its SaaS platform provides information on healthcare providers and their activities to help its customers from product development to go-to-market planning, and sales and marketing execution.